Harsh Thakkar

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

High Resolution Mass Spectrometry

Ultra High Performance Liquid Chromatography

Top Venues

Analytical methods : advancing methods and applications

Journal of the American Society for Mass Spectrometry

Journal of proteome research

This page only lists publications with an associated author ORCID identifier.

Publications

Harsh Thakkar, Shriya Gangakhedkar, Ravi P Shah
Bioanalysis of Stress Biomarkers through Sensitive HILIC-MS/MS Method: A Stride toward Accurate Quantification of MDA, ACR, and CTA. Journal of the American Society for Mass Spectrometry 35 (6) (2024)
Harsh Thakkar, Shriya Gangakhedkar, Ravi P Shah
Bioanalysis of Stress Biomarkers through Sensitive HILIC-MS/MS Method: A Stride toward Accurate Quantification of MDA, ACR, and CTA. Journal of the American Society for Mass Spectrometry (2024)
Harsh Thakkar, Shriya Gangakhedkar, Ravi P Shah
Bioanalysis of Stress Biomarkers through Sensitive HILIC-MS/MS Method: A Stride toward Accurate Quantification of MDA, ACR, and CTA. Journal of the American Society for Mass Spectrometry (2024)
Harsh Thakkar, Sayan Chatterjee, Purvi Saxena, Rameswari Eerla, Sachin Wagh, Amit Khairnar, Ravi P Shah
Cell-Engineered Recombinant α-Synuclein: A Gage R&R Validated Protocol. Journal of proteome research (2023)
Harsh Thakkar, Rameswari Eerla, Lokesh Sharma, Ravi P Shah
A rapid discriminative hydrogen-deuterium exchange and LC-HRMS/MS strategy for primary and higher order structural mapping of therapeutic proteins: a case study using filgrastim. Analytical methods : advancing methods and applications 15 (12) (2023)
Harsh Thakkar, Rameswari Eerla, Lokesh Sharma, Ravi P Shah
A rapid discriminative hydrogen-deuterium exchange and LC-HRMS/MS strategy for primary and higher order structural mapping of therapeutic proteins: a case study using filgrastim. Analytical methods : advancing methods and applications (2023)
Harsh Thakkar, Kalyani Sharma, Nancy Goyal, Ravi P Shah
LC-HRMS studies on ruxolitinib degradation: a comprehensive approach during drug development. Analytical methods : advancing methods and applications 14 (4) (2022)